The Thailand Hub of Talents in Cancer Immunotherapy (TTCI) is proud to have co-organized and led the Cell Therapy Program on the first day of the IPOPI-SEAPID-Chulalongkorn-Erasmus MC Meeting,...
• Researchers have developed a new drug called αPD-L1 × αCD3 BIPE that helps the immune system better target and kill non-small cell lung cancer cells by connecting cancer-fighting...
Nagoya, Japan – The Japanese Association of Cancer Immunology (JACI) will host its 29th Annual Meeting from July 24th-26th, 2025, at WINC AICH, Nagoya, Japan. This marks the first...
Researchers have developed a new method to treat multiple myeloma, a type of blood cancer. They engineered a type of immune cell called T cells to produce and release...
Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...
Prince Mahidol Award Youth Program Conference 2025 Focuses on Immunotherapy in Solid TumorsBangkok, Thailand The Prince Mahidol Award Youth Program Conference 2025 will take place on January 28, 2025,...
Scientists have created a new type of drug, called KTX207, that works by specifically instructing cells to destroy certain proteins, rather than just blocking them. This new drug targets...
Siriraj Hematology and SiAML (Siriraj Adult Acute Myeloid/Lymphoblastic Leukemia excellent center) For more details, please visit their:Official website: Facebook page: https://www.facebook.com/share/1AoeT5GeX5/?mibextid=LQQJ4d Facebook Twitter Line
Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Siriraj Hospital, Faculty of Medicine, Mahidol University For more details, please visit their:Official website: https://sgh.md.chula.ac.th/research/2087/Facebook page: Facebook Twitter Line
Researchers have developed a new approach to T cell therapy that is more effective and less toxic than current treatments. This new approach uses bispecific T cell engagers (BITEs)...